CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance SAMG Q1 2026 Earnings EPS Misses Estimates by Over 36 Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Focuses on Pipeline Progress PXED Q1 2026 Earnings EPS Surges Past Estimates by 656 as BottomLine Strength Defies Broad Market Headwinds GDEV Q4 2025 Earnings EPS Miss Pressures Stock Despite Lack of Revenue Disclosure SCSC Q1 2026 Earnings Slight EPS Miss Amid Mixed Operating Environment